Structure-based drug discovery of carbonic anhydrase inhibitors

Article Properties
Cite
Supuran, Claudiu T. “Structure-Based Drug Discovery of Carbonic Anhydrase Inhibitors”. Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 27, no. 6, 2012, pp. 759-72, https://doi.org/10.3109/14756366.2012.672983.
Supuran, C. T. (2012). Structure-based drug discovery of carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(6), 759-772. https://doi.org/10.3109/14756366.2012.672983
Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2012;27(6):759-72.
Refrences
Title Journal Journal Categories Citations Publication Date
Novel therapies for glaucoma: a patent review 2007 – 2011 Expert Opinion on Therapeutic Patents
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
103 2012
Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon speciesAcipenser gueldenstaedti Journal of Enzyme Inhibition and Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Biology (General)
  • Medicine: Therapeutics. Pharmacology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
49 2011
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium Bioorganic & Medicinal Chemistry Letters
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Organic chemistry
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
58 2011
Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives Bioorganic & Medicinal Chemistry Letters
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Organic chemistry
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
23 2011
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides Bioorganic & Medicinal Chemistry Letters
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Organic chemistry
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
26 2011
Citations
Title Journal Journal Categories Citations Publication Date
Design, synthesis, and biological evaluation of 3‐benzenesulfonamide‐linked 3‐hydrazinoisatin derivatives as carbonic anhydrase inhibitors

Archiv der Pharmazie
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: General. Including alchemy
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
2024
Sulfonamide‐incorporated bis(α‐aminophosphonates) as promising carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and X‐ray crystallographic studies

Archiv der Pharmazie
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: General. Including alchemy
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
2024
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors

ChemMedChem
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
2024
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets Pharmacology & Therapeutics
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
1 2024
Isosteviol – A new scaffold for the synthesis of carbonic anhydrase II inhibitors Results in Chemistry
  • Science: Chemistry: General. Including alchemy
2024
Citations Analysis
Category Category Repetition
Medicine: Therapeutics. Pharmacology356
Science: Biology (General)280
Science: Chemistry271
Science: Chemistry: Analytical chemistry205
Science: Chemistry: Organic chemistry172
Science: Chemistry: Organic chemistry: Biochemistry151
Medicine: Public aspects of medicine: Toxicology. Poisons66
Science: Chemistry: General. Including alchemy63
Technology: Chemical technology: Polymers and polymer manufacture29
Science: Physics13
Science: Microbiology13
Science: Chemistry: Physical and theoretical chemistry11
Science: Biology (General): Genetics8
Technology: Chemical technology: Biotechnology5
Medicine: Medicine (General)5
Science: Biology (General): Cytology5
Science: Chemistry: Inorganic chemistry4
Science: Physics: Nuclear and particle physics. Atomic energy. Radioactivity4
Medicine4
Science: Chemistry: Crystallography3
Science: Science (General)3
Technology: Engineering (General). Civil engineering (General)3
Technology: Chemical technology3
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials3
Science2
Science: Physics: Atomic physics. Constitution and properties of matter2
Technology: Chemical technology: Chemical engineering2
Technology: Environmental technology. Sanitary engineering2
Medicine: Internal medicine: Infectious and parasitic diseases2
Medicine: Pharmacy and materia medica2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry2
Technology: Technology (General): Industrial engineering. Management engineering1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology1
Science: Biology (General): Ecology1
Medicine: Medicine (General): Medical technology1
Science: Physiology1
Science: Mathematics: Instruments and machines: Electronic computers. Computer science1
Technology1
Medicine: Internal medicine: Special situations and conditions: Arctic medicine. Tropical medicine1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens1
The category Medicine: Therapeutics. Pharmacology 356 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit α- and β-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms and was published in 2012. The most recent citation comes from a 2024 study titled Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery. This article reached its peak citation in 2015, with 84 citations. It has been cited in 112 different journals, 22% of which are open access. Among related journals, the Journal of Enzyme Inhibition and Medicinal Chemistry cited this research the most, with 98 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year